Can rivaroxaban be a drug of choice for treating heparin-induced thrombocytopenia in a patient with pulmonary thromboembolism?

Anatol J Cardiol. 2017 Jul;18(1):77-79. doi: 10.14744/AnatolJCardiol.2017.7805.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anticoagulants / adverse effects*
  • Electrocardiography
  • Factor Xa Inhibitors / therapeutic use*
  • Heparin / adverse effects*
  • Humans
  • Male
  • Pulmonary Embolism / diagnostic imaging
  • Pulmonary Embolism / drug therapy*
  • Rivaroxaban / therapeutic use*
  • Thrombocytopenia / chemically induced
  • Thrombocytopenia / drug therapy*
  • Tomography, X-Ray Computed
  • Video Recording

Substances

  • Anticoagulants
  • Factor Xa Inhibitors
  • Heparin
  • Rivaroxaban